Investors & Supporters
Creating long-term value with differentiated RNA therapies.
ValamAi aims to create substantial long-term value by bringing new, differentiated RNA therapies to patients.
As we advance our platform and pipeline toward the clinic, we welcome conversations with strategic and financial partners who share that mission.
Investor and supporter details will be listed here as they are finalized.
Interested in investing?
If you are an investor interested in ValamAi, we would be glad to hear from you.
IND
FDA IND clearance for lead program VMB-100 in stress urinary incontinence.
4
Programs across urology, orthopedics & spine, dermatology and oncology.
1st
Composition of Matter patent allowed for our signal peptide technology.